Schedule: Monday - Saturday - 0:00 - 0:00, Sunday - 0:00 - 0:00
Ongoing Studies
Outcomes and prognostic factors in patients with Primary Mediastinal B Cell Lymphoma: real world data - PMBCL Study
Principal Investigator: Dr. Akhil
Mixed phenotypic acute leukemia -Clinical presentation and outcomes of patients treated with ALL like protocols a multi-institutional study from India. - M PAL Study
Principal Investigator: Dr Santhosh K D
Outcomes of patients with newly diagnosed Acute Myeloid Leukemia - a real world data
Principal Investigator: Dr. Vikram Mathews
Patterns of care and outcome in AYA lymphomas- A multicentre registry study from India
Principal Investigator: Dr. Lingaraj Nayak
To study outcomes in young CML treated with TKI in India
Principal Investigator: Dr Kundan Mishra
Outcomes of Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ve ALL): Analysis from the database of the Hematology Cancer Consortium
Principal Investigator: Dr Prasanth Ganesan
Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study
CTRI Registration No: CTRI/2020/07/026450
COVID-19 with Hematological Cancers Registry of India (CHCRI)
Upcoming Studies
Phase III open labeled randomized controlled study to evaluate the optimal dose of all-trans retinoic acid in the treatment of low and intermediate risk acute promyelocytic leukemia
A phase III randomized study to compare a risk-stratified and response-adapted strategy to ABVD regimen in adolescents and adults with advanced-stage Hodgkin lymphoma
CTRI Registration No: CTRI/2020/12/030132
